NCT00673283 Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging Status COMPLETED Phase EARLY_PHASE1
NCT00672841 β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients Status COMPLETED Phase NA
NCT00672594 Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy Status COMPLETED Phase PHASE2
NCT00672256 Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence Status COMPLETED Phase NA
NCT00672243 Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme Status COMPLETED Phase PHASE2
NCT00672178 Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC) Status TERMINATED Phase PHASE1/PHASE2
NCT00671970 Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) Status COMPLETED Phase PHASE2
NCT00661336 A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma Status WITHDRAWN Phase PHASE1
NCT00650091 Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Status COMPLETED Phase PHASE3
NCT00638040 The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression Status WITHDRAWN Phase N/A
NCT00637520 Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study Status TERMINATED Phase N/A
NCT00636805 Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab Status TERMINATED Phase PHASE2